Literature DB >> 8674273

Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts.

B P Himelstein1, R J Muschel.   

Abstract

Tumor-stromal interactions appear to play an important role in the induction of metalloproteinase expression in malignant tumors. We describe a tissue culture system in which expression of MMP-9 (gelatinase B or the 92 kDa type IV collagenase/gelatinase) was induced by co-cultivation of fibroblasts with breast cancer cell lines. While neither the breast cancer cells nor the normal rat embryo fibroblasts made MMP-9 alone in culture, human MMP-9 was made in the co-cultures. The MMP-9 was secreted in a latent form. The induction occurred at least in part through increases in the MMP-9 mRNA levels in the breast cancer cells. These increases did not appear to require protein synthesis. Conditioned medium from the fibroblasts could duplicate the induction of MMP-9 in the breast cancer cell lines. The active factor in the medium was inactivated by heat or by trypsin suggesting that it was a protein. This protein was in the size range of 30-100 kDa. Thus, fibroblasts could secrete a factor which was able to regulate the expression of MMP-9 in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674273     DOI: 10.1007/bf00053892

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  53 in total

1.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.

Authors:  H G Welgus; E J Campbell; J D Cury; A Z Eisen; R M Senior; S M Wilhelm; G I Goldberg
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.

Authors:  M Ballin; D E Gomez; C C Sinha; U P Thorgeirsson
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

3.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.

Authors:  C M Overall; J L Wrana; J Sodek
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

4.  Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha.

Authors:  Y Okada; H Tsuchiya; H Shimizu; K Tomita; I Nakanishi; H Sato; M Seiki; K Yamashita; T Hayakawa
Journal:  Biochem Biophys Res Commun       Date:  1990-09-14       Impact factor: 3.575

5.  Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.

Authors:  B Davies; J Waxman; H Wasan; P Abel; G Williams; T Krausz; D Neal; D Thomas; A Hanby; F Balkwill
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

6.  Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines.

Authors:  E N Unemori; M S Hibbs; E P Amento
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells.

Authors:  A C Noël; M Polette; J M Lewalle; C Munaut; H P Emonard; P Birembaut; J M Foidart
Journal:  Int J Cancer       Date:  1994-02-01       Impact factor: 7.396

8.  Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.

Authors:  J Ochieng; R Fridman; P Nangia-Makker; D E Kleiner; L A Liotta; W G Stetler-Stevenson; A Raz
Journal:  Biochemistry       Date:  1994-11-29       Impact factor: 3.162

9.  Human 92- and 72-kilodalton type IV collagenases are elastases.

Authors:  R M Senior; G L Griffin; C J Fliszar; S D Shapiro; G I Goldberg; H G Welgus
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

10.  The effect of E1A transfection on MMP-9 expression and metastatic potential.

Authors:  E J Bernhard; B Hagner; C Wong; I Lubenski; R J Muschel
Journal:  Int J Cancer       Date:  1995-03-03       Impact factor: 7.396

View more
  5 in total

1.  Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.

Authors:  K Shibata; F Kikkawa; A Nawa; K Tamakoshi; N Suganuma; Y Tomoda
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.

Authors:  S Mc Donnell; V Chaudhry; J Mansilla-Soto; Z S Zeng; W P Shu; J G Guillem
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

Review 3.  Recruitment and retention: factors that affect pericyte migration.

Authors:  Kristina Y Aguilera; Rolf A Brekken
Journal:  Cell Mol Life Sci       Date:  2013-08-04       Impact factor: 9.261

4.  Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.

Authors:  S Ishigaki; M Toi; T Ueno; H Matsumoto; M Muta; M Koike; M Seiki
Journal:  Jpn J Cancer Res       Date:  1999-05

5.  PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1).

Authors:  Jyotica Batra; Jessica Robinson; Christine Mehner; Alexandra Hockla; Erin Miller; Derek C Radisky; Evette S Radisky
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.